Menicon Co., Ltd. is a Japan-based company mainly engaged in operation of contact lens related business and other business. The Company has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.

Employees

4,221

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/11/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
13/24/13	1,303.00 ¥	+0.54%	407,000
12/24/12	1,296.00 ¥	+2.57%	315,000
11/24/11	1,263.50 ¥	-3.37%	403,900
10/24/10	1,307.50 ¥	-0.04%	192,400
09/24/09	1,308.00 ¥	-2.68%	338,400

Delayed Quote Japan Exchange, September 13, 2024 at 11:30 am IST

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,303.00JPY

Average target price

2,216.00JPY

Spread / Average Target

+70.07%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Japan Exchange Other stock markets 11:30:00 13/09/2024 am IST			5-day change	1st Jan Change
1,303.00 ^JPY	+0.54%		-3.05%	-44.53%

09/08	Menicon Co., Ltd. Provides Consolidated Financial Guidance for the Fiscal Year Ending March 31, 2025	CI
09/08	Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	CI

Capitalization	9.87TCr 70Cr 5.88TCr	P/E ratio 2025 *	13x	P/E ratio 2026 *	12.7x
Enterprise value	14TCr 102.56Cr 8.6TCr	EV / Sales 2025 *	1x	EV / Sales 2026 *	0.94x
Free-Float	81.3%	Yield 2025 *	2.28%	Yield 2026 *	2.47%

Menicon Co., Ltd. Provides Consolidated Financial Guidance for the Fiscal Year Ending March 31, 2025	09/08	CI
Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	09/08	CI
Menicon Launches Eco-Friendly Lawn Grass for Sustainable Greenery	09/08	MT
Menicon Co., Ltd. Starts the Deployment of Greening with the Next-Generation Japanese Lawn Grass "Naruoturf®"	08/08	CI
Menicon Grants 330 Units of Share Remuneration-Type Stock Options	27/06	MT
Menicon Reintroduces Employee Stock Ownership Plan	30/05	MT
Menicon Establishes German Subsidiary and Alters Capital Increase Payment Timing	05/04	MT
Menicon Buys French Specialty Contact Lens Maker Dencott	04/04	MT
Menicon Co., Ltd. acquired Laboratoires Dencott.	04/04	CI
Menicon Boosts Capital of Germany Unit Menicon SC, Making it Specified Subsidiary	26/03	MT
Menicon Acquires New Site for Manufacturing Hub	12/03	MT
Menicon Co., Ltd. Announces Acquisition of Fukui New Site in Hokuriku Area to Manufacture and Production of Contact Lenses and Lens Care Products	11/03	CI
Tohoku University, The University of Tokyo, and Menicon Co., Ltd. to Start Joint Research on Fundamental Technology for Contact Lenses	01/03	CI

Menicon : Notice of Acquisition of Fixed Assets	26/22/26	PU
Menicon : Notice of transfer of specified subsidiary	26/22/26	PU
Menicon : Daily Disposable Lens “1DAY Menicon PremiO multifocal” Launch in Japan	11/22/11	PU
Menicon : ［Delayed］Notice of transfer of specified subsidiary (sub-subsidiary)	08/21/08	PU
Menicon : Subsidiary Opens Eye Health Science Museum in China	17/21/17	PU

Menicon Co., Ltd. Share Price

Equities

7780

JP3921270009

Medical Equipment, Supplies & Distribution

Valuation: Menicon Co., Ltd.

Chart: Menicon Co., Ltd.

Latest news: Menicon Co., Ltd.

Press Releases: Menicon Co., Ltd.

News in other languages: Menicon Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Menicon Co., Ltd.

ETFs: Menicon Co., Ltd.

Glasses, Spectacles & Contact Lenses

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

1 day	+0.54%
1 week	-3.05%
Current month	-4.82%
1 month	-1.77%
3 months	+3.37%
6 months	-19.86%
Current year	-44.53%

Director	Title	Age	Since
Hidenari Tanaka CEO	Chief Executive Officer	64	01/87/01
Hideki Koga DFI	Director of Finance/CFO	-	-
Motonari Watanabe CTO	Chief Tech/Sci/R&D Officer	51	01/97/01

Name	Weight	AuM	1st Jan change	Investor Rating
NOMURA NEXT FUNDS TOPIX-17 ELECTRIC APPLIANCES & PRECISION INSTRUMENTS ETF - JPY	0.18%	34 M€	+7.03%
NOMURA NEXT FUNDS NOMURA ENTERPRISE VALUE ALLOCATION INDEX ETF - JPY	0.06%	74 M€	+8.14%
NZAM ETF TOPIX EX-FINANCIALS - JPY	0.04%	18 M€	+18.02%	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
MENICON CO., LTD.	+0.54%	-3.05%	-35.83%	-71.95%	70Cr
ESSILORLUXOTTICA	0.00%	0.00%	+20.06%	+23.23%	11TCr
ALCON INC.	-1.65%	+5.07%	+14.55%	+7.02%	4.86TCr
THE COOPER COMPANIES, INC.	+1.53%	+3.70%	+28.29%	+0.35%	2.2TCr
AUTEK CHINA INC.	-2.39%	-2.60%	-48.09%	-79.70%	170.32Cr
WARBY PARKER INC.	+2.02%	+11.83%	+17.20%	-	175.56Cr
PEGAVISION CORPORATION	+0.50%	+0.75%	+15.16%	-26.42%	98Cr
SHANGHAI CONANT OPTICAL CO., LTD.	+3.18%	+4.23%	+123.82%	-	78Cr
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-0.42%	+10.44%	-26.66%	-11.70%	63Cr
JAPAN EYEWEAR HOLDINGS CO., LTD.	-15.50%	-12.67%	-	-	53Cr
Average	-1.22%	+1.77%	+12.06%	-22.74%	1.83TCr
Weighted average by Cap.	-0.28%	+1.88%	+18.96%	+14.32%

	2025 *	2026 *
Net sales	12TCr 88Cr 7.35TCr	13TCr 92Cr 7.76TCr
Net income	788.04Cr 5.59Cr 469.27Cr	799.98Cr 5.68Cr 476.39Cr
Net Debt	2.49TCr 18Cr 1.48TCr	2.42TCr 17Cr 1.44TCr

Manager	Title	Age	Since
Hidenari Tanaka CEO	Chief Executive Officer	64	01/87/01
Ryutaro Honda BRD	Director/Board Member	78	01/19/01
Yoshimi Horinishi BRD	Director/Board Member	56	01/16/01